BRPI0701085A - use of PAF receptor antagonist to treat flaviviridae infections - Google Patents

use of PAF receptor antagonist to treat flaviviridae infections

Info

Publication number
BRPI0701085A
BRPI0701085A BRPI0701085-0A BRPI0701085A BRPI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A BR PI0701085 A BRPI0701085 A BR PI0701085A
Authority
BR
Brazil
Prior art keywords
receptor antagonist
paf receptor
flaviviridae infections
treat flaviviridae
treat
Prior art date
Application number
BRPI0701085-0A
Other languages
Portuguese (pt)
Inventor
Teixeira Mauro Martins
Gloria De Souza Danielle Da
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BRPI0701085-0A priority Critical patent/BRPI0701085A/en
Publication of BRPI0701085A publication Critical patent/BRPI0701085A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Uso de antagonista do receptor do PAF para o tratamento de infecções causadas por Flaviviridae. A presente invençâo apresenta um novo medicamento de um produto já conhecido com uso no campo médico, para tratar doenças causadas por vírus da família Flaviviridae, especialmente Dengue e Febre de Dengue Hemorrágica (FDH) e Choque.Use of PAF receptor antagonist for the treatment of Flaviviridae infections. The present invention provides a novel medicament of a known product for use in the medical field to treat diseases caused by Flaviviridae viruses, especially Dengue and Hemorrhagic Dengue Fever (DHF) and Shock.

BRPI0701085-0A 2007-02-27 2007-02-27 use of PAF receptor antagonist to treat flaviviridae infections BRPI0701085A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0701085-0A BRPI0701085A (en) 2007-02-27 2007-02-27 use of PAF receptor antagonist to treat flaviviridae infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0701085-0A BRPI0701085A (en) 2007-02-27 2007-02-27 use of PAF receptor antagonist to treat flaviviridae infections

Publications (1)

Publication Number Publication Date
BRPI0701085A true BRPI0701085A (en) 2008-10-14

Family

ID=39832132

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0701085-0A BRPI0701085A (en) 2007-02-27 2007-02-27 use of PAF receptor antagonist to treat flaviviridae infections

Country Status (1)

Country Link
BR (1) BRPI0701085A (en)

Similar Documents

Publication Publication Date Title
CL2011000589A1 (en) Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.
PA8840801A1 (en) DIOXA-BICYCLE DERIVAOS [3.2.1] OCTANO-2,3,4-TRIOL
EA201290131A1 (en) Derivatives of Purine or Deazapurine for Use in the Treatment of Viral Infections and Other Diseases
BR112015013809A2 (en) exendin-4 derivatives as glp1 / gip double agonists or glp1 / gip / lucagon trigonals, their use and pharmaceutical composition
CY1116064T1 (en) DDP Suspension Recommendations IV
EA201300987A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING METHORMENE AND DPP-4 INHIBITOR OR SGLT-2 INHIBITOR
ECSP109903A (en) DERIVATIVES OF PIRAZINONA AND ITS USE IN THE TREATMENT OF PULMONARY DISEASES
UY30759A1 (en) CHEMICAL COMPOUNDS
ECSP088329A (en) NEW DIAZAESPIROALCANOS AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY CCR8
EA202091999A3 (en) APPLICATION OF DPP IV INHIBITORS
ECSP109934A (en) COMPOUND - 946
EA200901138A1 (en) DERIVATIVES OF DIANILINOPYRIMIDINE AS KEEIN INHIBITORS WEE1, PHARMACEUTICAL COMPOSITION AND USE
UY32174A (en) NEW SUBSTITUTED HETEROCICLES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
ECSP099685A (en) SULFUR COMPOUNDS AS INHIBITORS OF THE SERINA PROTEASA NS3 OF THE HEPATITIS C VIRUS
CY1111454T1 (en) PHYNYL-PYRAZOLI PRODUCTS AS CONNECTORS OF NON-STEROID GLYCOCORTICOIDS
CR20120289A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
CY1120435T1 (en) PHARMACEUTICAL FORMS INCLUDING CRYSTAL FORMS OF HYDROCHLORIC MONHYDROCHLORIDE (R) -7-CHLORO-N- (CINOCLIDINO-3-YL) V-2-YL
EA201070327A1 (en) CATECHOLAMINE DERIVATIVES AND THEIR DEVICES
UY30572A1 (en) N- (1-FTALAZIN-1-IL-PIPERIDIN-4-IL) -AMIDAS AS MODULATORS OF THE EP2 RECEIVER
ATE489371T1 (en) BENZAMIDE GLUCOCINASE ACTIVATORS
BRPI0820668A2 (en) 5-HALOGEN SUBSTITUTED OXINDOL DERIVATIVES AND THEIR USE TO TREAT VASOPRESSIN DEPENDENT DISEASES
AR071120A1 (en) DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF CHRONIC VENOUS DISEASES.
CY1118399T1 (en) Benzofuran compounds for viral infections c treatment
ECSP11011101A (en) CYCLOUNDECADEPSIPEPTIDE COMPOUNDS AND THE USE OF SUCH COMPOUNDS AS A MEDICINAL PRODUCT
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.

Legal Events

Date Code Title Description
B03A Publication of an application: publication of a patent application or of a certificate of addition of invention
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law
B07A Technical examination (opinion): publication of technical examination (opinion)
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL